309 related articles for article (PubMed ID: 34671112)
21. Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.
Westergaard N; Baltzer Houlind M; Christrup LL; Juul-Larsen HG; Strandhave C; Olesen AE
Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):531-542. PubMed ID: 38308569
[TBL] [Abstract][Full Text] [Related]
22. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
[TBL] [Abstract][Full Text] [Related]
23. Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.
Zhu Y; Swanson KM; Rojas RL; Wang Z; St Sauver JL; Visscher SL; Prokop LJ; Bielinski SJ; Wang L; Weinshilboum R; Borah BJ
Genet Med; 2020 Mar; 22(3):475-486. PubMed ID: 31591509
[TBL] [Abstract][Full Text] [Related]
24. Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease.
Elchynski AL; Cicali EJ; Ferrer Del Busto MC; Hamilton A; Chang KL; Schmidt SO; Weiner B; Davis R; Estores D; Max Smith D; Wiisanen K; Johnson JA; Cavallari LH
Pharmacogenomics J; 2021 Dec; 21(6):657-663. PubMed ID: 34075203
[TBL] [Abstract][Full Text] [Related]
25. Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients.
Niedrig DF; Rahmany A; Heib K; Hatz KD; Ludin K; Burden AM; Béchir M; Serra A; Russmann S
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361984
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence.
Schuh MJ; Crosby S
Innov Pharm; 2020; 11(2):. PubMed ID: 34007616
[TBL] [Abstract][Full Text] [Related]
27. Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer.
Bernard PS; Wooderchak-Donahue W; Wei M; Bray SM; Wood KC; Parikh B; McMillin GA
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799547
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics in Asians: Differences and similarities with other human populations.
Biswas M; Jinda P; Sukasem C
Expert Opin Drug Metab Toxicol; 2023 Jan; 19(1):27-41. PubMed ID: 36755439
[TBL] [Abstract][Full Text] [Related]
29. CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
J Mol Diagn; 2023 Sep; 25(9):619-629. PubMed ID: 37419245
[TBL] [Abstract][Full Text] [Related]
30. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
[TBL] [Abstract][Full Text] [Related]
31. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
[TBL] [Abstract][Full Text] [Related]
32. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
[No Abstract] [Full Text] [Related]
33. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
Alshabeeb MA; Alyabsi M; Paras B
Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
[TBL] [Abstract][Full Text] [Related]
34. Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.
Wick JA; Schmidlen T; Grande K; Moretz C; Ashcraft K; Green J; Moyer N; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(1):188-192. PubMed ID: 36243653
[TBL] [Abstract][Full Text] [Related]
35. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
[TBL] [Abstract][Full Text] [Related]
36. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
[TBL] [Abstract][Full Text] [Related]
37. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
Kim K; Magness JW; Nelson R; Baron V; Brixner DI
J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
[TBL] [Abstract][Full Text] [Related]
38. Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.
Fan M; Yarema MC; Box A; Hume S; Aitchison KJ; Bousman CA
Pharmacogenet Genomics; 2021 Feb; 31(2):29-39. PubMed ID: 32826605
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.
Rodríguez-Escudero I; Cedeño JA; Rodríguez-Nazario I; Reynaldo-Fernández G; Rodríguez-Vera L; Morales N; Jiménez-Vélez B; Ruaño G; Duconge J
J Am Coll Clin Pharm; 2020 Sep; 3(6):1028-1037. PubMed ID: 32964197
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenomics research and clinical implementation in Brazil.
Rodrigues-Soares F; Suarez-Kurtz G
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):538-549. PubMed ID: 30589990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
